The genetic fusion between the erythroblast transformation-specific (ETS) transcriptional factor ETS-related gene (ERG) and the androgen-responsive promotor transmembrane protease, serine 2 (TMPRSS2) [1] is suggested to be a major mechanism driving prostate carcinogenesis. Here, ERG is linked to prostatitis.